4//SEC Filing
Gaines Kristin Sallee 4
Accession 0001127602-23-014953
CIK 0000877860other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:59 PM ET
Size
22.9 KB
Accession
0001127602-23-014953
Insider Transaction Report
Form 4
Gaines Kristin Sallee
Chief Credit Officer
Transactions
- Award
Common Stock
2023-05-05+4,000→ 48,609 total
Holdings
- 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2021-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,333
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 18,333
Stock Options (Right to Buy) 2019
Exercise: $79.96From: 2020-02-21Exp: 2024-02-21→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2019
Exercise: $79.96From: 2021-02-21Exp: 2024-02-21→ Common Stock (18,334 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2020-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2022-02-21Exp: 2025-02-21→ Common Stock (18,334 underlying) - 18,334
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (18,334 underlying) - 8,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (8,334 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 18,333
Stock Options (Right to Buy) 2019
Exercise: $79.96From: 2019-02-21Exp: 2024-02-21→ Common Stock (18,333 underlying) - 18,333
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2023-02-25Exp: 2026-02-25→ Common Stock (18,334 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying)
Footnotes (1)
- [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting May 5, 2024
Documents
Issuer
NATIONAL HEALTH INVESTORS INC
CIK 0000877860
Entity typeother
Related Parties
1- filerCIK 0001455833
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 7:59 PM ET
- Size
- 22.9 KB